Crown-ether cyanide treatment, which simply involves immersion in KCN solutions containing 18-crown-6 followed by rinse, is studied in relation to electrical and optical properties of nitrogen-doped, polycrystalline Cu2O thin films, and its effect is compared with that of hydrogen treatment. By the crown-ether cyanide treatment, the luminescence intensity due to the near-band-edge emission of Cu2O at around 680 nm is enhanced, and the hole density is increased from the order of 1016 to 1017 cm−3, analogous to hydrogen treatment. The effects of the passivation by the hydrogen treatment completely disappear after annealing at 350 °C, while those of the crown-ether cyanide treatment stay unchanged after the same annealing treatment. From these results, the crown-ether cyanide treatment for polycrystalline Cu2O thin films can be concluded to be a more suitable method of passivating defects than the hydrogen treatment.
PACS 73.61. Ga, 81.15.Cd, 84.60.Jt Polycrystalline n-ZnO/p-Cu 2 O heterojunctions were fabricated by reactive sputtering for photovoltaic applications. Although electrical rectification was not reproducibly obtained in the as-grown samples, rectification was observed in the samples fabricated with cyanide treated Cu 2 O. We have previously shown that cyanide treatment has an effective role in passivation of defects in Cu 2 O, in analogy to hydrogen passivation. It is, therefore, believed that the observed improvement in the electrical rectification of the ZnO/Cu 2 O heterojunctions is attributable to the defect passivation near the hetero-interface. The effectiveness of the cyanide treatment and the importance of defect passivation in ZnO/Cu 2 O heterojunctions are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.